These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15908379)

  • 1. Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.
    Watts A; Ke D; Wang Q; Pillay A; Nicholson-Weller A; Lee JC
    Infect Immun; 2005 Jun; 73(6):3502-11. PubMed ID: 15908379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.
    Liu B; Park S; Thompson CD; Li X; Lee JC
    Virulence; 2017 Aug; 8(6):859-874. PubMed ID: 27936346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus capsular polysaccharide types 5 and 8 reduce killing by bovine neutrophils in vitro.
    Kampen AH; Tollersrud T; Lund A
    Infect Immun; 2005 Mar; 73(3):1578-83. PubMed ID: 15731056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates.
    Park S; Gerber S; Lee JC
    Infect Immun; 2014 Dec; 82(12):5049-55. PubMed ID: 25245803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice.
    Tuchscherr LP; Buzzola FR; Alvarez LP; Caccuri RL; Lee JC; Sordelli DO
    Infect Immun; 2005 Dec; 73(12):7932-7. PubMed ID: 16299284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence.
    Luong TT; Lee CY
    Infect Immun; 2002 Jul; 70(7):3389-95. PubMed ID: 12065477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.
    Thakker M; Park JS; Carey V; Lee JC
    Infect Immun; 1998 Nov; 66(11):5183-9. PubMed ID: 9784520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis.
    Nilsson IM; Lee JC; Bremell T; Rydén C; Tarkowski A
    Infect Immun; 1997 Oct; 65(10):4216-21. PubMed ID: 9317029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of cell-associated CP5 expression on Staphylococcus aureus strains demonstrated by flow cytometry.
    Poutrel B; Rainard P; Sarradin P
    Clin Diagn Lab Immunol; 1997 May; 4(3):275-8. PubMed ID: 9144363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats.
    Lee JC; Park JS; Shepherd SE; Carey V; Fattom A
    Infect Immun; 1997 Oct; 65(10):4146-51. PubMed ID: 9317020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses.
    Sordelli DO; Buzzola FR; Gomez MI; Steele-Moore L; Berg D; Gentilini E; Catalano M; Reitz AJ; Tollersrud T; Denamiel G; Jeric P; Lee JC
    J Clin Microbiol; 2000 Feb; 38(2):846-50. PubMed ID: 10655395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a gene essential for O-acetylation of the Staphylococcus aureus type 5 capsular polysaccharide.
    Bhasin N; Albus A; Michon F; Livolsi PJ; Park JS; Lee JC
    Mol Microbiol; 1998 Jan; 27(1):9-21. PubMed ID: 9466251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typing of Staphylococcus aureus isolated from bovine mastitis cases in Australia and India.
    Gogoi-Tiwari J; Babra Waryah C; Sunagar R; Veeresh HB; Nuthanalakshmi V; Preethirani PL; Sharada R; Isloor S; Bhat A; Al-Salami H; Hegde NR; Mukkur TK
    Aust Vet J; 2015 Aug; 93(8):278-82. PubMed ID: 26220320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States.
    Mohamed N; Timofeyeva Y; Jamrozy D; Rojas E; Hao L; Silmon de Monerri NC; Hawkins J; Singh G; Cai B; Liberator P; Sebastian S; Donald RGK; Scully IL; Jones CH; Creech CB; Thomsen I; Parkhill J; Peacock SJ; Jansen KU; Holden MTG; Anderson AS
    PLoS One; 2019; 14(1):e0208356. PubMed ID: 30641545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus.
    Lee JC; Takeda S; Livolsi PJ; Paoletti LC
    Infect Immun; 1993 May; 61(5):1853-8. PubMed ID: 8478074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides by CO(2).
    Herbert S; Newell SW; Lee C; Wieland KP; Dassy B; Fournier JM; Wolz C; Döring G
    J Bacteriol; 2001 Aug; 183(15):4609-13. PubMed ID: 11443096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides.
    Tzianabos AO; Wang JY; Lee JC
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9365-70. PubMed ID: 11470905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus Cap5O has UDP-ManNAc dehydrogenase activity and is essential for capsule expression.
    Portolés M; Kiser KB; Bhasin N; Chan KH; Lee JC
    Infect Immun; 2001 Feb; 69(2):917-23. PubMed ID: 11159986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Staphylococcus aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis.
    Kuipers A; Stapels DAC; Weerwind LT; Ko YP; Ruyken M; Lee JC; van Kessel KPM; Rooijakkers SHM
    Microbiology (Reading); 2016 Jul; 162(7):1185-1194. PubMed ID: 27112346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I.
    Cunnion KM; Hair PS; Buescher ES
    Infect Immun; 2004 May; 72(5):2858-63. PubMed ID: 15102797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.